Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Robert E. Roses, MD

Robert E. Roses, MD Surgeon

Assistant Professor of Surgery at the Hospital of the University of Pennsylvania

Dr. Roses is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Endocrine and Oncologic Surgery

Programs & Centers:

Board Certification:

  • Surgery, 2011

Clinical Expertise:

  • Adrenal Cancer
  • Adrenal Gland Tumors
  • Bile Duct Cancer
  • Carcinoid Tumors
  • Gallbladder Cancer
  • Gastrointestinal Cancer
  • Gastrointestinal Stromal Tumors (GIST)
  • Liver Cancer
  • Liver Tumors
  • Neuroendocrine Tumors
  • Pancreatic Cancer
  • Retroperitoneal Sarcoma
  • Small Intestine Cancer
  • Stomach Cancer (Gastric Cancer)
  • Stomach Tumors

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • UnitedHealthcare Community Plan

Education and Training

Medical School:
Residency: Hospital of the University of Pennsylvania
Fellowship: University of Texas - MD Anderson Cancer Center


American College of Surgeons, National North American Neuroendocrine Tumor Society, National Society of Surgical Oncology, International

Hospital Affiliation

Dr. Roses is employed by Penn Medicine.


Selected Publications:

Roses RE, Tzeng CW, Ross MI, Fournier KF, Abbott DE: The palliative index: predicting outcomes of emergent surgery in patients with cancer. J Palliat Med 17 (1): 37-42,2014.

Datta J, Lewis RS Jr, Mamtani R, Stripp D, Kelz RR, Drebin JA, Fraker DL, Karakousis GC: Implications of inadequate lymph node staging in resectable gastric cancer: A contemporary analysis using the National Cancer Data Base Cancer 120 (18): 2855-65,2014.

Roses RE: The management of rectal cancer Current Surgical Therapy, 11th edition : 2014.

Roses RE, Bartlett EK, Kelz RR, Drebin JA, Fraker DL: Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database Surgery 156 (2): 298-304,2014.

Bartlett EK1, Wachtel H, Fraker DL, Vollmer CM, Drebin JA, Kelz RR, Karakousis GC: Surgical Palliation for Pancreatic Malignancy: Practice Patterns and Predictors of Morbidity and Mortality J Gastrointest Surg 18 (7): 1292-8,2014.

Dionisi F, Avery S, Lukens JN, Ding X, Kralik J, Kirk M, Roses RE, Amichetti M, Metz JM: Proton therapy in adjuvant treatment of gastric cancer: Planning comparison with advanced x-ray therapy and feasibility report. Acta Oncol 53 (10): 1312-20,2014.

Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G: Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg 217 (6): 1028-37,2013.

Fracol M, Xu S, Mick R, Fitzpatrick E, Nisenbaum H, Roses R, Fisher C, Tchou J, Fox K, Zhang P: Response to HER-2 Pulsed DC1 Vaccines is Predicted by Both HER-2 and Estrogen Receptor Expression in DCIS. Ann Surg Oncol 20 (10): 3233-9,2013.

Bansal N, Sonnenberg EM, Meise CK, Reinke CE, Karakousis GC, Bartlett EK, Mahmoud NN, Roses RE: The effect of colorectal cancer screening mandates on access to care and clinical outcomes: a retrospective study of patients undergoing operations of the colon and rectum. Surgery 154 (2): 335-44,2013.

Roses RE: Malignant Melanoma Surgery: Evidence-Based Practice : 2013.

Bartlett EK, Roses RE, Meise C, Fraker DL, Kelz RR: Preoperative radiation for retroperitoneal sarcoma is not associated with increased early postoperative morbidity. J Surg Oncol 109 (6): 606-11,2013.

Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, Xu X, Elder DE, Ming M, Elenitsas R, Guerry D, Kelz RR, Czerniecki BJ, Fraker DL: Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy. Ann Surg Oncol 21 (2): 643-9,2013.

Roses RE: Hepatocellular Carcinoma: Epidemiology, Staging, Medical Management. Abrams Angiography, 3rd edition : 2013.

Bartlett EK, Meise C, Roses RE, Fraker DL, Kelz RR: Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database. Ann Surg Oncol 21 (5): 1494-500,2013.

Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL: Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma Cancer 119 (18): 3334-42,2013.

Bartlett EK, Meise C, Bansal N, Fischer JP, Low DW, Czerniecki BJ, Roses RE, Fraker DL, Kelz RR: Sartorius transposition during inguinal lymphadenectomy for melanoma J Surg Res 184 (1): 209-15,2013.

Royal RE: Cancer of the Pancreas and Hepatobiliary Tracts Oncology in Primary Care : 2013.

Bartlett EK, Roses RE, Gupta M, Shah PK, Shah KK, Zaheer S, Wachtel H, Kelz RR, Karakousis GC: Surgery for metastatic neuroendocrine tumors with occult primaries J Surg Res 184 (1): 221-7,2013.

Roses RE: Incisions, Closures, and Management of the Abdominal Wound Maingot's Abdominal Operations, 12th Edition : 99-122,2013.

You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA. Feig BW, Slack R, Nguyen S: Multimodality salvage of recurrent disease after local excision for rectal cancer Dis Colon Rectum 55 (12): 1213-9,2012.

Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA: Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections J Gastrointestinal Surg : 2012.

Roses RE: Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies Current Cancer Therapy Reviews 8 : 182-188,2012.

Kaseb AO, Abaza YM: Multidisciplinary management of hepatocellular carcinoma Recent Results Cancer Res 190 : 247-59,2013.

You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW: Multimodality salvage of failure after local excision for rectal cancer Oral Presentation at the Annual Meeting of the American Society of Colon and Rectal Surgeons, San Antonio, TX : 2012.

Roses RE, Kuerer HM, Albarracin CT, Lari SA: Phenotype of Pure DCIS in BRCA Mutation Carriers Poster presentation at the 2012 Annual Symposium of the Society of Surgical Oncology, Orlando, FL : 2012.

Roses RE, Zimmitti G, Aloia T, Andreou A, Curley S: Greater complexity of liver surgery is not associated with an increased incidence of liver related complications except for bile leak: an experience with 2628 consecutive resections Oral presentation at the annual meeting of the Society for Surgery of the Alimentary Tract, San Diego, CA : 2012.

Roses RE, Foley PJ, Paulson EC, Pray L, Kelz RR, Williams NN: Revisiting the rotation call schedule in under 80 hours per week Oral Presentation at the Association of the Program Directors in Surgery Annual Meeting, Salt Lake City, UT : 2009.

Roses RE, Arun B, Lari S, Mittendorf EA: Ductal Carcinoma in situ of the breat and subsequent distant metastases Poster Presentation at the 2011 Annual Cancer Symposium of the Society of Surgical Oncology, San Antonio, TX : 2011.

Roses RE, Paulson EC, Kanchwala SK: Gowned and Gloved Introduction to Common Procedures : 2010.

Porrett P, Frederick J, Roses RE: The Surgical Review 3rd Edition : 2009.

Roses RE: The breast The Surgical Review, Third Edition : 252-262,2010.

Sentinel lymph node biopsy and axillary dissection Gowned and Gloved Surgery; Introduction to Common Procedures : 202-209,2009.

Roses RE: Mastectomy Gowned and Gloved Surgery: Introduction to Common Procedures : 188-194,2009.

Rodriguez JA, Roses RE: Appendectomy Gowned and Gloved Surgery: Introduction to Common Procedures : 123-130,2009.

Paulson EC, Roses RE: Laparoscopic Cholecystectomy Gowned and Gloved Surgery: Introduction to Common Procedures : 92-101,2009.

Roses RE, Kanchwala SK: Perioperative Care Gowned and Gloved Surgery: Introduction to Common Procedures : 1-7,2009.

Roses RE, Xu M, Xu S, Koldovsky U, Son G: Working towards the development of vaccines for the treatment of of early breast cancer Current Cancer Therapy Reviews 3 : 97-107,2007.

Khitin L, Roses RE: Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg 60 (5): 521-3,2003.

Xu JW, Zaporojan V, Peretti GM, Roses RE, Morse KB, Roy AK, Mesa JM, Randolph MA, Bonassar LJ: Injectable tissue-engineered cartilage with different chondrocyte sources. Plast Reconstr Surg 113 (5): 1361-71,2004.

Xu JW, Randolph MA, Peretti GM, Nazzal JA, Roses RE, Morse KR: Producing a flexible tissue-engineered cartilage framework using expanded polytetrafluoroethylene membrane as a pseudoperichondrium. Plast Reconstr Surg 116 (2): 577-89,2005.

Peretti GM, Campo-Ruiz V, Gonzalez S, Randolph MA, Xu JW, Morse KR, Roses RE: Tissue engineered cartilage integration to live and devitalized cartilage: a study by reflectance mode confocal microscopy and standard histology. Connect Tissue Res 47 (4): 190-9,2006.

Czerniecki BJ, Roses RE: Development of vaccines for high-risk ductal carcinoma in situ of the breast. Cancer Res 67 (14): 6531-4,2007.

Karakousis GC, Han D, Kelz RR, Nemani D, Karamacharya J, Roses RE, Gimotty PA: Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT). Surgery 142 (6): 845-50; discussion 850.e1-2,2007.

Roses RE, Xu M, Koski GK: Radiation therapy and toll-like receptor signaling: implications for the treatment of cancer. Oncogene 27 (2): 200-7,2008.

Koski GK, Cohen PA, Roses RE, Xu S: Reengineering dendritic cell-based anti-cancer vaccines. Immunol Rev 222 : 256-76,2008.

Roses RE, Xu S, Xu M, Koldovsky U, Koski G: Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol 181 (7): 5120-7,2008.

Foley PJ, Roses RE, Kelz RR, Resnick AS, Williams NN, Mullen JL, Kaiser LR: The state of general surgery training: a different perspective. J Surg Educ 65 (6): 494-8,2008.

Roses RE, Paulson EC, Sharma A, Schueller JE, Nisenbaum H, Weinstein S, Fox KR, Zhang PJ: HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 18 (5): 1386-9,2009.

Bahl S, Roses RE, Sharma A, Koldovsky U, Xu S, Weinstein S, Nisenbaum H, Fox K, Pasha T, Zhang P, Araujo L, Carver J: Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccines. Am J Surg 198 (4): 488-94,2009.

Roses RE, Foley PJ, Paulson EC, Pray L, Kelz RR, Williams NN: Revisiting the rotating call schedule in less than 80 hours per week. J Surg Educ 66 (6): 357-60,2009.

Roses RE, Arun BK, Lari SA, Mittendorf A, Lucci A, Hunt KK: Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol 18 (10): 2873-8,2011.

Aburabia MD, Roses RE, Kuerer HM, Fine R, Beitsch PD, Goyal S, Haffty B, Lyden M: Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Ann Surg Oncol 18 (12): 3415-21,2011.

Harada S, Mick R, Roses RE, Graves H, Niu H, Sharma A, Schueller JE, Nisenbaum H, Czerniecki BJ: The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease. J Surg Oncol 104 (5): 458-65,2011.

Sharma A, Koldovsky U, Xu S, Mick R, Roses RE, Fitzpatrick E, Weinstein S, Nisenbaum H, Levine BL, Fox K, Zhang P, Koski G: HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. Cancer 118 (17): 4354-62,2012.

Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK: Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 19 (12): 3777-84,2012.

Academic Contact Info

3400 Spruce Street
4 Silverstein Pavillion

Philadelphia, PA 19104
Phone: (215) 662-2068
Patient appointments: 800-789-7366 (PENN)